|
Real-time Estimate
Cboe BZX
22:28:07 27/10/2026 +03
|
5-day change | 1st Jan Change | ||
| 37.92 USD | +1.24% |
|
-2.86% | -9.89% |
| 10-12 | UBS Initiates Coverage on Nektar Therapeutics With Neutral Rating, $53 Price Target | MT |
| 10-12 | Leerink Partners Initiates Nektar Therapeutics at Outperform, $130 Price Target | MT |
Chart: Technical Analysis
NasdaqUSD
| Markets | Quality | ||
|---|---|---|---|
Nasdaq
| NKTR | Delayed | |
CBOE
| NKTR | Real-time | |
|
Tradegate
| ITH0 | Real-time | |
|
Deutsche Boerse AG
| ITH0 | Delayed | |
|
Börse Stuttgart
| ITH0 | Delayed | |
|
Boerse Muenchen
| ITH0 | Real-time | |
|
Xetra
| ITH0 | Delayed |
Technical analysis trends
| Short Term | Mid-Term | Long Term | |
|---|---|---|---|
| Trend | Bearish | Bearish | Bearish |
| Resistance | 48.57 | 60.54 | 57.32 |
| Spread/Res. | -21.56% | -37.07% | -33.53% |
| Spread/Supp. | +6.48% | +6.48% | +6.48% |
| Support | 35.78 | 35.78 | 35.78 |
MarketScreener's Technical Analysis Ratings
| Short Term Timing | |
|---|---|
| Middle Term Timing | |
| Long Term Timing | |
| RSI | |
| Bollinger Spread | |
| Unusual Volumes |
- Stock Market
- Stocks
- NKTR Stock
- Charts Nektar Therapeutics
Select your edition
All financial news and data tailored to specific country editions
